Cantel Medical (CMD) Tops Q4 EPS by 1c

Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $205.5 million versus the consensus estimate of $200.32 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
• NextEra Energy (NEE) Tops Q1 EPS by 16c, provides guidance